Anti-Complement component C9 (human)

Mouse monoclonal antibody

Cat.No. ABS 004-53

Subclass IgG1/k
Presentation:

Preparation: Protein-A/G purified
Content: Available in 200 µL and 1 mL size.1 mg/mL +/- 15%. See Certificate of Analysis for details.
Solvent: 0.01 M phosphate buffer, pH 7.4, with 0.5 M NaCl and 15 mM sodium azide
Storage: 4-8ºC without exposure to light. No precautions necessary during handling.

Antigen:

Complement factor C9 is a 71kDa single-chain ellipsoid a-globular molecule of 558 amino acids including a leader sequence of 20 amino acids. C9 bind the C5b8 complex on membranes and has an unique property in forming tubular structures containing between 12 and 18 monomers, closely resembling the membrane attack complex (MAC). The primary site of synthesis is hepatocytes, secondary sites are monocytes, fibroblasts and glial cells. The normal level of C9 in plasma is 60 µg/mL, and the level is up regulated from hepatocytes by IFN-g.

Immunogen:

Complement factor C9 adsorbed onto aluminum hydroxide gel

Specificity:

ABS 004-53 is specific for complement factor C9

Epitope specificity:

Not determined

Reactivity:

ABS 004-02 recognizes C9 in human serum diluted 1/50 in Tris buffer (20 mM Tris-base, 1 mM MgCl2, 1 mM CaCl2 and 140 mM NaCl) and incubated for 2 hours at 37°C using a human IgM coated (10 µg/mL overnight at 4°C, blocked with PBS 7.2 + 1% BSA for 1 hour) ELISA plate.

Application:
Method Usability References
ELISA Yes
Immunoblotting Not determined
Immunohistochemistry Not determined
References:

The Complement Facts Book. 2000. Bernard J. Morlay and Mark J. Walport (eds.). Academic Press, London.

BioPorto - Grusbakken 8, DK-2820 Gentofte, Denmark
Phone: (+45) 4529 0000 - Fax: (+45) 4529 0001 - Email: info@bioporto.com

Created by Wizkids ApShttp://wizkids.dk